![Olivier Danos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Olivier Danos
Directeur Technique/Scientifique/R&D chez
REGENXBIO INC.
Profil
Olivier Danos was the founder of Lysogene SA, founded in 2009, and served as Director from 2017 to 2018.
Current jobs include Chairman-Scientific Advisory Board at Firalis SA since 2012, Independent Non-Executive Director at Horama SA since 2021, Director at Profilomic SA since 2016, Director at uniQure France SAS, and Chief Scientific Officer & EVP at REGENXBIO, Inc. since 2017.
Former jobs include Senior Director-Research at Somatix Therapy Corp.
from 1994 to 1996, Research Director at Centre National de la Recherche Scientifique, Director-Gene Therapy Consortium at University College London from 2008 to 2011, Senior Vice President-Cell & Gene Therapy at Biogen, Inc. from 2014 to 2017, President & Founding Member at European Society of Gene & Cell Therapy, Chief Scientific Officer at Genethon from 1998 to 2005, and Senior VP-Molecular Medicine & Synthetic Biology at Kadmon Pharmaceuticals LLC from 2011 to 2014.
Education includes graduate studies at the University of Orsay and a doctorate from Université Paris Diderot-Paris 7.
Dr. Danos is the founder.
Postes actifs de Olivier Danos
| Sociétés | Poste | Début |
|---|---|---|
| REGENXBIO INC. | Directeur Technique/Scientifique/R&D | 28/03/2017 |
Firalis SA
 Firalis SA BiotechnologyHealth Technology Engages in the discovery and development of biomarker-based diagnostics | Corporate Officer/Principal | - |
Profilomic SA
 Profilomic SA Medical/Nursing ServicesHealth Services Provides services in chemical, lipidomic and metabolomic analyses | Directeur/Membre du Conseil | 27/10/2016 |
Corlieve Therapeutics SAS
 Corlieve Therapeutics SAS Pharmaceuticals: MajorHealth Technology Develops transformational medicines for neurological diseases | Directeur/Membre du Conseil | - |
Horama SA
 Horama SA BiotechnologyHealth Technology Develops gene therapies for eye diseases | Directeur/Membre du Conseil | 12/10/2021 |
Anciens postes connus de Olivier Danos
| Sociétés | Poste | Fin |
|---|---|---|
| LYSOGENE | Fondateur | 01/04/2018 |
| BIOGEN INC. | Corporate Officer/Principal | 01/03/2017 |
Kadmon Pharmaceuticals LLC
 Kadmon Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Corporate Officer/Principal | 01/09/2014 |
University College London
 University College London Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/12/2011 |
| ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Olivier Danos
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
82
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Somatix Therapy Corp.
 Somatix Therapy Corp. BiotechnologyHealth Technology Provides biological products | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
REGENXBIO, Inc.
 REGENXBIO, Inc. Pharmaceuticals: MajorHealth Technology Develops gene therapy | Health Technology |
University College London
University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Orsay
 University of Orsay Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université Paris Diderot-Paris 7
 Université Paris Diderot-Paris 7 Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Centre National de la Recherche Scientifique
 Centre National de la Recherche Scientifique General GovernmentGovernment Provides scientific research services | Government |
European Society of Gene & Cell Therapy | |
Kadmon Pharmaceuticals LLC
Kadmon Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Genethon
 Genethon BiotechnologyHealth Technology Develops gene therapy products for rare diseases | Health Technology |
Firalis SA
Firalis SA BiotechnologyHealth Technology Engages in the discovery and development of biomarker-based diagnostics | Health Technology |
Lysogene SA
 Lysogene SA BiotechnologyHealth Technology Engages in research and clinical development of gene therapy for neurodegenerative disorders | Health Technology |
Horama SA
Horama SA BiotechnologyHealth Technology Develops gene therapies for eye diseases | Health Technology |
Profilomic SA
Profilomic SA Medical/Nursing ServicesHealth Services Provides services in chemical, lipidomic and metabolomic analyses | Health Services |
Corlieve Therapeutics SAS
Corlieve Therapeutics SAS Pharmaceuticals: MajorHealth Technology Develops transformational medicines for neurological diseases | Health Technology |
